
- Telehealth Visits
- Insurance plan information


Caroline Shiboski, DDS, PhD
Dentistry- Telehealth Visits
- Insurance plan information




Caroline Shiboski, DDS, PhD
Dentistry- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Caroline H. Shiboski cares for adult and pediatric patients with oral mucosal diseases and other oral disorders. These include inflammatory conditions (lichen planus, pemphigus, pemphigoid), infectious diseases (such as candidiasis and herpes virus infections), certain oral pain conditions (such as burning mouth syndrome) and the oral complications of graft-versus-host disease, which may develop following a stem cell transplant. She is also involved with the initial diagnosis of oral cancer and precancerous conditions, and works closely with the head and neck surgery team for timely referral and treatment.
Shiboski's research focuses on the possible oral manifestations of immune system dysfunction, oral cancer and Sjögren's disease.
Shiboski earned her doctor of dental surgery degree from Paris Descartes University in France. She completed a residency in oral medicine at UCSF. She earned a master of public health degree in epidemiology and a doctorate in epidemiology at the University of California, Berkeley.
Shiboski is a member of the American Association for Dental Research, International Association for Dental Research, American Dental Association, California Dental Association, American Academy of Oral Medicine, San Francisco Dental Society and American College of Rheumatology.
Education & training
Board certification
- Oral Medicine, American Board of Oral Medicine
Fellowship
- UCSF Medical Center GME/RESEARCH
Residency
- Dentistry, UCSF Medical Center - OMAG
Degree
- DDS, Universite de Paris V
My expertise
Specialties
- Dentistry
Locations
My research
Publications
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.